-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS - TO SUBMIT SND A FOR PLOZASIRAN IN SHTG TO FDA BY YEAR-END 2026

Reuters·10/07/2026 11:32:12